Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients

INTRODUCTION: In this phase III, open-label, single-arm, multi-center 12-week study, we evaluated the efficacy and safety of combination therapy with sucroferric oxyhydroxide (PA21) and calcium carbonate for hemodialysis patients with hyperphosphatemia. METHODS: We enrolled 35 subjects aged ≥ 20 yea...

全面介紹

Na minha lista:
書目詳細資料
發表在:Kidney Int Rep
Main Authors: Koiwa, Fumihiko, Yokoyama, Keitaro, Fukagawa, Masafumi, Akizawa, Tadao
格式: Artigo
語言:Inglês
出版: Elsevier 2017
主題:
Clinical Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5762971/
https://ncbi.nlm.nih.gov/pubmed/29340330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2017.10.003
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍